Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4)

被引：25
|
作者：
Oishi, Shinya [1 ]
Fujii, Nobutaka [1 ]
机构：
[1] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan
来源：
ORGANIC & BIOMOLECULAR CHEMISTRY | 2012年 / 10卷 / 30期
关键词：
ANTI-HIV PEPTIDE; IMMUNODEFICIENCY-VIRUS ACTIVITY; CELL FUSION INHIBITOR; N-TERMINAL PEPTIDES; SMALL-MOLECULE; SYNTHETIC PEPTIDE; BONE-MARROW; FACTOR-I; THERAPEUTIC TARGET; PHARMACOPHORE IDENTIFICATION;
D O I：
10.1039/c2ob25107h
中图分类号：
O62 [有机化学];
学科分类号：
070303 ; 081704 ;
摘要：
The development of novel peptide and peptidomimetic ligands for the CXC chemokine receptor 4 (CXCR4) as therapeutic agents for HIV-1 infection, cancer, and immune system diseases has grown over the last decade. In this perspective article, the design of CXCR4 agonists and antagonists from endogenous stromal cell-derived factor-1 (SDF-1)/CXCL12 and horseshoe crab-derived antimicrobial peptides and their therapeutic and diagnostic applications are described.
引用
收藏
页码：5720 / 5731
页数：12
相关论文
共 50 条
  • [31] Clinical relevance of chemokine receptor CXCR4
    Gebura, Katarzyna
    Bogunia-Kubik, Katarzyna
    [J]. POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2012, 66 : 252 - 266
  • [32] Development of Novel CXC Chemokine Receptor 7 (CXCR7) Ligands: Selectivity Switch from CXCR4 Antagonists with a Cyclic Pentapeptide Scaffold
    Oishi, Shinya
    Kuroyanagi, Tomoko
    Kubo, Tatsuhiko
    Montpas, Nicolas
    Yoshikawa, Yasushi
    Misu, Ryosuke
    Kobayashi, Yuka
    Ohno, Hiroaki
    Heveker, Nikolaus
    Furuya, Toshio
    Fujii, Nobutaka
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (13) : 5218 - 5225
  • [33] Design, synthesis, and biological evaluation of scaffold-based tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4)
    Zachariassen, Zack G.
    Thiele, Stefanie
    Berg, Erik A.
    Rasmussen, Pernille
    Fossen, Torgils
    Rosenkilde, Mette M.
    Vabeno, Jon
    Haug, Bengt Erik
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (17) : 4759 - 4769
  • [34] CXC chemokine receptor 4 (CXCR4) targeted gold nanoparticles potently enhance radiotherapy outcomes in breast cancer
    Bhattarai, Shanta
    Mackeyev, Yuri
    Venkatesulu, Bhanu P.
    Krishnan, Sunil
    Singh, Pankaj K.
    [J]. NANOSCALE, 2021, 13 (45) : 19056 - 19065
  • [35] A role for the CXCR4 chemokine receptor in lesioninduced neurogenesis
    Kolodziej, A
    Stumm, R
    Henrich-Noack, P
    Reymann, K
    Hoellt, V
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 77 - 77
  • [36] The role of chemokine receptor CXCR4 in lung cancer
    Gangadhar, Tara
    Nandi, Suvobroto
    Salgia, Ravi
    [J]. CANCER BIOLOGY & THERAPY, 2010, 9 (06)
  • [37] The dynamics of chemokine receptor CXCR4 endocytosis.
    Rosselli-Murai, L. K.
    DeNies, M.
    White, M.
    Liu, A. P.
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2016, 27
  • [38] Role of the chemokine receptor CXCR4 in Waldenstrom Macroglobulinemia
    Ghobrial, IM
    Melhem, M
    Singha, U
    George, D
    Timm, M
    Francis, L
    Alsayed, Y
    Huston, A
    Roodman, GD
    Greipp, P
    Gertz, M
    Witzig, T
    [J]. BLOOD, 2005, 106 (11) : 291A - 292A
  • [39] Chemokine receptor CXCR4: Role in gastrointestinal cancer
    Lombardi, Lucia
    Tavano, Francesca
    Morelli, Franco
    Latiano, Tiziana Pia
    Di Sebastiano, Pierluigi
    Maiello, Evaristo
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 88 (03) : 696 - 705
  • [40] The good and bad faces of the CXCR4 chemokine receptor
    Teixido, Joaquin
    Martinez-Moreno, Monica
    Diaz-Martinez, Marta
    Sevilla-Movilla, Silvia
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2018, 95 : 121 - 131
12345